LANXESS AG (LXS.DE) Fundamental Analysis & Valuation

FRA:LXS • DE0005470405

Current stock price

11.65 EUR
-0.17 (-1.44%)
Last:

This LXS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. LXS.DE Profitability Analysis

1.1 Basic Checks

  • LXS had positive earnings in the past year.
  • In the past year LXS had a positive cash flow from operations.
  • Of the past 5 years LXS 4 years were profitable.
  • In the past 5 years LXS always reported a positive cash flow from operatings.
LXS.DE Yearly Net Income VS EBIT VS OCF VS FCFLXS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

  • LXS has a worse Return On Assets (-2.97%) than 70.00% of its industry peers.
  • The Return On Equity of LXS (-6.23%) is worse than 72.86% of its industry peers.
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROIC N/A
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
LXS.DE Yearly ROA, ROE, ROICLXS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • LXS's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 20.52%, LXS is not doing good in the industry: 74.29% of the companies in the same industry are doing better.
  • LXS's Gross Margin has declined in the last couple of years.
  • LXS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.52%
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
LXS.DE Yearly Profit, Operating, Gross MarginsLXS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. LXS.DE Health Analysis

2.1 Basic Checks

  • LXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LXS remains at a similar level compared to 1 year ago.
  • LXS has more shares outstanding than it did 5 years ago.
  • LXS has a better debt/assets ratio than last year.
LXS.DE Yearly Shares OutstandingLXS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXS.DE Yearly Total Debt VS Total AssetsLXS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • LXS has an Altman-Z score of 1.82. This is not the best score and indicates that LXS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LXS has a Altman-Z score of 1.82. This is in the lower half of the industry: LXS underperforms 65.71% of its industry peers.
  • LXS has a debt to FCF ratio of 22.13. This is a negative value and a sign of low solvency as LXS would need 22.13 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 22.13, LXS is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • LXS has a Debt/Equity ratio of 0.62. This is a neutral value indicating LXS is somewhat dependend on debt financing.
  • The Debt to Equity ratio of LXS (0.62) is worse than 62.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Altman-Z 1.82
ROIC/WACCN/A
WACC4.14%
LXS.DE Yearly LT Debt VS Equity VS FCFLXS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • LXS has a Current Ratio of 2.60. This indicates that LXS is financially healthy and has no problem in meeting its short term obligations.
  • LXS has a better Current ratio (2.60) than 80.00% of its industry peers.
  • A Quick Ratio of 1.29 indicates that LXS should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.29, LXS is doing good in the industry, outperforming 67.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 1.29
LXS.DE Yearly Current Assets VS Current LiabilitesLXS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. LXS.DE Growth Analysis

3.1 Past

  • LXS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.28%.
  • Measured over the past years, LXS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.38% on average per year.
  • The Revenue has decreased by -6.82% in the past year.
  • The Revenue has been decreasing by -1.32% on average over the past years.
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%

3.2 Future

  • Based on estimates for the next years, LXS will show a decrease in Earnings Per Share. The EPS will decrease by -0.75% on average per year.
  • Based on estimates for the next years, LXS will show a decrease in Revenue. The Revenue will decrease by -0.33% on average per year.
EPS Next Y-79.17%
EPS Next 2Y-45.74%
EPS Next 3Y-16.71%
EPS Next 5Y-0.75%
Revenue Next Year-10.25%
Revenue Next 2Y-5.73%
Revenue Next 3Y-2.98%
Revenue Next 5Y-0.33%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LXS.DE Yearly Revenue VS EstimatesLXS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
LXS.DE Yearly EPS VS EstimatesLXS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. LXS.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.14, the valuation of LXS can be described as correct.
  • Based on the Price/Earnings ratio, LXS is valued cheaply inside the industry as 84.29% of the companies are valued more expensively.
  • LXS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.23.
  • With a Price/Forward Earnings ratio of 25.05, LXS can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LXS indicates a slightly more expensive valuation: LXS is more expensive than 67.14% of the companies listed in the same industry.
  • LXS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.14
Fwd PE 25.05
LXS.DE Price Earnings VS Forward Price EarningsLXS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LXS is valued cheaply inside the industry as 88.57% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, LXS is valued cheaper than 95.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.98
EV/EBITDA 5.05
LXS.DE Per share dataLXS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • LXS's earnings are expected to decrease with -16.71% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-45.74%
EPS Next 3Y-16.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LXS.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.85%, LXS is not a good candidate for dividend investing.
  • The stock price of LXS dropped by -31.51% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • LXS's Dividend Yield is slightly below the industry average, which is at 2.39.
  • Compared to an average S&P500 Dividend Yield of 1.89, LXS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.85%

5.2 History

  • The dividend of LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr Years0
Div Non Decr Years1
LXS.DE Yearly Dividends per shareLXS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • LXS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • LXS's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-4.12%
EPS Next 2Y-45.74%
EPS Next 3Y-16.71%
LXS.DE Yearly Income VS Free CF VS DividendLXS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

More info and screens

Find the best dividend stocksShow peers with best dividend

LXS.DE Fundamentals: All Metrics, Ratios and Statistics

LANXESS AG

FRA:LXS (3/20/2026, 7:00:00 PM)

11.65

-0.17 (-1.44%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-19
Earnings (Next)05-07
Inst Owners71.41%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap1.01B
Revenue(TTM)5.89B
Net Income(TTM)-243.00M
Analysts55.71
Price Target19.72 (69.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.85%
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-4.12%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)292.85%
Min EPS beat(2)79.47%
Max EPS beat(2)506.23%
EPS beat(4)4
Avg EPS beat(4)279.29%
Min EPS beat(4)79.47%
Max EPS beat(4)506.23%
EPS beat(8)8
Avg EPS beat(8)234.01%
EPS beat(12)11
Avg EPS beat(12)164.45%
EPS beat(16)14
Avg EPS beat(16)126.78%
Revenue beat(2)0
Avg Revenue beat(2)-8.07%
Min Revenue beat(2)-8.49%
Max Revenue beat(2)-7.66%
Revenue beat(4)0
Avg Revenue beat(4)-5.7%
Min Revenue beat(4)-8.49%
Max Revenue beat(4)-1.78%
Revenue beat(8)1
Avg Revenue beat(8)-4.92%
Revenue beat(12)2
Avg Revenue beat(12)-4.05%
Revenue beat(16)3
Avg Revenue beat(16)-5.05%
PT rev (1m)3.67%
PT rev (3m)-5.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.37%
EPS NY rev (1m)1.77%
EPS NY rev (3m)-29.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.8%
Valuation
Industry RankSector Rank
PE 12.14
Fwd PE 25.05
P/S 0.17
P/FCF 8.98
P/OCF 2.33
P/B 0.26
P/tB 0.6
EV/EBITDA 5.05
EPS(TTM)0.96
EY8.24%
EPS(NY)0.47
Fwd EY3.99%
FCF(TTM)1.3
FCFY11.13%
OCF(TTM)5
OCFY42.94%
SpS68.19
BVpS45.2
TBVpS19.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.25
Profitability
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.52%
FCFM 1.9%
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Debt/EBITDA 4.55
Cap/Depr 50.71%
Cap/Sales 5.43%
Interest Coverage N/A
Cash Conversion 81.82%
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 1.29
Altman-Z 1.82
F-Score6
WACC4.14%
ROIC/WACCN/A
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
EPS Next Y-79.17%
EPS Next 2Y-45.74%
EPS Next 3Y-16.71%
EPS Next 5Y-0.75%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%
Revenue Next Year-10.25%
Revenue Next 2Y-5.73%
Revenue Next 3Y-2.98%
Revenue Next 5Y-0.33%
EBIT growth 1Y82.42%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1008.93%
EBIT Next 3Y134.6%
EBIT Next 5Y73.71%
FCF growth 1Y-74.13%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y-44.97%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%

LANXESS AG / LXS.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for LANXESS AG?

ChartMill assigns a fundamental rating of 3 / 10 to LXS.DE.


Can you provide the valuation status for LANXESS AG?

ChartMill assigns a valuation rating of 5 / 10 to LANXESS AG (LXS.DE). This can be considered as Fairly Valued.


What is the profitability of LXS stock?

LANXESS AG (LXS.DE) has a profitability rating of 2 / 10.


Can you provide the financial health for LXS stock?

The financial health rating of LANXESS AG (LXS.DE) is 4 / 10.


What is the expected EPS growth for LANXESS AG (LXS.DE) stock?

The Earnings per Share (EPS) of LANXESS AG (LXS.DE) is expected to decline by -79.17% in the next year.